inhibitor-BEC (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View inhibitor-BEC's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
inhibitor-BEC Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	SCGB2A1 Gene (Entity type)	0.0051097996
2-((E)-3-naphthalene-2-yl-but-2-enoylamino)-benzoic acid Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	inhibitor-BEC Compound (Entity type)	0.3634794950485229
inhibitor-BEC Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	RPS4Y1 Gene (Entity type)	0.00457066
inhibitor-BEC Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	HMOX1 Gene (Entity type)	-0.008129133
inhibitor-BEC Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	HMGCS1 Gene (Entity type)	-0.0066209505
inhibitor-BEC Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	SERPINA1 Gene (Entity type)	0.0072688484
inhibitor-BEC Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	NTRK2 Gene (Entity type)	0.0057907705
inhibitor-BEC Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	Teniposide Compound (Entity type)	0.4184601008892059
inhibitor-BEC Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	UGT2B28 Gene (Entity type)	0.0052442993
inhibitor-BEC Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	methotrexate Compound (Entity type)	0.3945131599903106

inhibitor-BEC
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
SCGB2A1
Gene (Entity type)
0.0051097996

2-((E)-3-naphthalene-2-yl-but-2-enoylamino)-benzoic acid
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
inhibitor-BEC
Compound (Entity type)
0.3634794950485229

inhibitor-BEC
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
RPS4Y1
Gene (Entity type)
0.00457066

inhibitor-BEC
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
HMOX1
Gene (Entity type)
-0.008129133

inhibitor-BEC
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
HMGCS1
Gene (Entity type)
-0.0066209505

inhibitor-BEC
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
SERPINA1
Gene (Entity type)
0.0072688484

inhibitor-BEC
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
NTRK2
Gene (Entity type)
0.0057907705

inhibitor-BEC
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
Teniposide
Compound (Entity type)
0.4184601008892059

inhibitor-BEC
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
UGT2B28
Gene (Entity type)
0.0052442993

inhibitor-BEC
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
methotrexate
Compound (Entity type)
0.3945131599903106

DISPLAY PER PAGE

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.